Novartis Institute for Tropical Diseases (NITD)
Description
Description
State-of-the-art biomedical research institute for tropical diseases. Objective is to develop novel compounds and find partners for clinical development, manufacturing, marketing and distribution. No profit from poor people in developing countries, but potential for profitable operations in developed markets (re-financing the research costs). Initial focus on Dengue-fever and treatment-resistant tuberculosis.
Partners
Governments:
Government of Singapore - Singapore Economic Development Board
Major Groups:
Novartis (Switzerland)
Medecins sans Frontieres ()
various ()
Other intergovernmental organizations:
WHO (Switzerland)
Government of Singapore - Singapore Economic Development Board
Major Groups:
Novartis (Switzerland)
Medecins sans Frontieres ()
various ()
Other intergovernmental organizations:
WHO (Switzerland)
SDGS & Targets
N/A
SDG 14 targets covered
Deliverables & Timeline
N/A
Resources mobilized
N/A
Partnership Progress
No progress reports have been submitted.
Please sign in and click here to submit one.
False
Feedback
Action Network
This initiative does not yet fulfil the SMART criteria.
Share
Timeline
01 January 1970 (start date)
03 April 2012 (date of completion)
Entity
N/A
Goals
N/A
More information
Countries
N/A